Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
32.246 (89/276) |
1.39E-32 |
NIMA-related kinase 7 (NEK7)
|
|
26.962 (79/293) |
1.45E-24 |
Omphalocele kinase 1 (NUAK1)
|
|
29.388 (72/245) |
2.42E-23 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.828 (61/256) |
1.18E-22 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
29.297 (75/256) |
1.42E-22 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
29.151 (79/271) |
4.53E-22 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
28.685 (72/251) |
6.58E-22 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
27.888 (70/251) |
1.38E-21 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
29.020 (74/255) |
2.42E-21 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
27.600 (69/250) |
5.92E-21 |
Aurora kinase A (AURKA)
|
|
27.925 (74/265) |
7.35E-21 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
27.888 (70/251) |
1.49E-20 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
29.224 (64/219) |
5.50E-20 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
29.362 (69/235) |
7.17E-20 |
Salt-inducible kinase 2 (SIK2)
|
|
30.493 (68/223) |
7.58E-20 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
30.888 (80/259) |
1.01E-19 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
29.412 (70/238) |
1.09E-19 |
Myosin light chain kinase 2 (MYLK2)
|
|
30.804 (69/224) |
1.16E-19 |
Aurora kinase C (AURKC)
|
|
26.848 (69/257) |
1.19E-19 |
Polo-like kinase 4 (PLK4)
|
|
27.692 (72/260) |
1.85E-19 |
Polo-like kinase 2 (PLK2)
|
|
25.794 (65/252) |
2.11E-19 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
26.502 (75/283) |
2.81E-19 |
NIMA-related kinase 6 (NEK6)
|
|
25.524 (73/286) |
5.51E-19 |
Salt-inducible kinase 1 (SIK1)
|
|
29.596 (66/223) |
1.05E-18 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
29.596 (66/223) |
1.15E-18 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
28.571 (68/238) |
1.43E-18 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
24.603 (62/252) |
1.89E-18 |
SIK family kinase 3 (SIK3)
|
|
30.088 (68/226) |
1.97E-18 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
30.970 (83/268) |
2.44E-18 |
Cyclin-dependent kinase 15 (CDK15)
|
|
31.441 (72/229) |
3.10E-18 |
Death-associated protein kinase 2 (DAPK2)
|
|
27.419 (68/248) |
3.57E-18 |
Protein kinase C beta (PRKCB)
|
|
28.636 (63/220) |
3.87E-18 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
29.032 (63/217) |
4.10E-18 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
30.660 (65/212) |
4.40E-18 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
25.000 (68/272) |
4.89E-18 |
Myosin light chain kinase 3 (MYLK3)
|
|
31.925 (68/213) |
5.70E-18 |
Protein kinase C alpha (PRKCA)
|
|
25.620 (62/242) |
6.42E-18 |
Cyclin-dependent kinase 2 (CDK2)
|
|
26.800 (67/250) |
8.45E-18 |
Cyclin-dependent kinase 3 (CDK3)
|
|
27.706 (64/231) |
8.69E-18 |
Fused homolog (STK36)
|
|
27.619 (58/210) |
1.34E-17 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
28.094 (84/299) |
1.36E-17 |
Aurora kinase B (AURKB)
|
|
26.335 (74/281) |
1.45E-17 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
26.744 (69/258) |
2.20E-17 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
29.600 (74/250) |
3.39E-17 |
Death-associated protein kinase 3 (DAPK3)
|
|
27.826 (64/230) |
3.53E-17 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
27.823 (69/248) |
4.60E-17 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
25.397 (64/252) |
7.89E-17 |
Unc-51 like kinase 3 (ULK3)
|
|
28.627 (73/255) |
9.78E-17 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
25.000 (84/336) |
1.07E-16 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
28.405 (73/257) |
1.07E-16 |
Polo-like kinase 1 (PLK1)
|
|
27.488 (58/211) |
2.18E-16 |
Cyclin-dependent kinase 16 (CDK16)
|
|
29.245 (62/212) |
2.74E-16 |
Protein kinase C gamma (PRKCG)
|
|
28.319 (64/226) |
2.82E-16 |
MEK kinase kinase 1 (MAP4K1)
|
|
26.217 (70/267) |
2.85E-16 |
Serine/threonine-protein kinase 33 (STK33)
|
|
29.310 (68/232) |
3.05E-16 |
Death-associated protein kinase 1 (DAPK1)
|
|
28.947 (66/228) |
3.09E-16 |
NIMA-related kinase 1 (NEK1)
|
|
20.800 (52/250) |
4.82E-16 |
Cyclin-dependent kinase 1 (CDK1)
|
|
27.350 (64/234) |
5.73E-16 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
29.412 (65/221) |
6.31E-16 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
23.922 (61/255) |
6.37E-16 |
BR serine/threonine kinase 1 (BRSK1)
|
|
26.275 (67/255) |
6.97E-16 |
BR serine/threonine kinase 2 (BRSK2)
|
|
28.311 (62/219) |
8.09E-16 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
25.896 (65/251) |
1.02E-15 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
28.000 (70/250) |
1.46E-15 |
Myosin light kinase (MYLK)
|
|
26.126 (58/222) |
3.23E-15 |
Cyclin-dependent kinase 14 (CDK14)
|
|
29.245 (62/212) |
3.99E-15 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
28.829 (64/222) |
4.04E-15 |
Cyclin-dependent kinase 5 (CDK5)
|
|
26.761 (57/213) |
5.79E-15 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
26.641 (69/259) |
6.62E-15 |
Serine/threonine-protein kinase 26 (STK26)
|
|
26.906 (60/223) |
7.59E-15 |
Cyclin-dependent kinase 17 (CDK17)
|
|
26.887 (57/212) |
7.64E-15 |
Protein kinase C delta (PRKCD)
|
|
28.700 (64/223) |
7.72E-15 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
27.556 (62/225) |
8.25E-15 |
CaM-kinase IV kinase (CAMKK1)
|
|
32.143 (54/168) |
8.35E-15 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
27.586 (56/203) |
8.66E-15 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
26.337 (64/243) |
1.10E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
27.273 (66/242) |
1.20E-14 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
21.622 (48/222) |
1.25E-14 |
NIMA-related kinase 2 (NEK2)
|
|
29.730 (55/185) |
1.25E-14 |
Protein kinase C theta (PRKCQ)
|
|
24.183 (74/306) |
1.79E-14 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
21.622 (48/222) |
2.22E-14 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
26.482 (67/253) |
2.36E-14 |
Cyclin-dependent kinase 18 (CDK18)
|
|
27.358 (58/212) |
2.70E-14 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
28.364 (78/275) |
2.77E-14 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
25.820 (63/244) |
3.66E-14 |
MAP kinase p38 (MAPK12)
|
|
28.249 (50/177) |
3.98E-14 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.481 (72/262) |
4.59E-14 |
Misshapen-like kinase 1 (MINK1)
|
|
25.000 (52/208) |
5.33E-14 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
24.921 (79/317) |
6.03E-14 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
26.848 (69/257) |
6.41E-14 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
30.120 (50/166) |
6.51E-14 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
26.471 (54/204) |
7.08E-14 |
Serine/threonine-protein kinase MAK (MAK)
|
|
27.638 (55/199) |
7.08E-14 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
29.924 (79/264) |
8.46E-14 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.934 (57/197) |
8.59E-14 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
30.000 (69/230) |
9.09E-14 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
25.681 (66/257) |
9.17E-14 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
25.877 (59/228) |
1.19E-13 |
Protein kinase C epsilon (PRKCE)
|
|
26.027 (57/219) |
1.25E-13 |
Serine/threonine-protein kinase 24 (STK24)
|
|
26.540 (56/211) |
1.35E-13 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
28.958 (75/259) |
1.38E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
25.952 (75/289) |
1.54E-13 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
25.862 (60/232) |
2.29E-13 |
MST-1 protein kinase (STK4)
|
|
25.581 (55/215) |
2.69E-13 |
Cyclin-dependent kinase 13 (CDK13)
|
|
27.805 (57/205) |
3.33E-13 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
29.808 (62/208) |
3.50E-13 |
Serine/threonine-protein kinase 25 (STK25)
|
|
28.125 (54/192) |
4.65E-13 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
25.200 (63/250) |
4.85E-13 |
Stress-activated protein kinase 2b (p38 beta)
|
|
27.917 (67/240) |
4.97E-13 |
Serine/threonine-protein kinase 3 (STK3)
|
|
25.701 (55/214) |
5.14E-13 |
Doublecortin-like kinase 3 (DCLK3)
|
|
25.641 (50/195) |
5.21E-13 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
28.426 (56/197) |
6.67E-13 |
ERK activator kinase 5 (MAP2K5)
|
|
26.210 (65/248) |
7.63E-13 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
27.193 (62/228) |
8.62E-13 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
28.992 (69/238) |
8.88E-13 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
27.451 (70/255) |
1.34E-12 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
23.346 (60/257) |
1.43E-12 |
Cyclin-dependent kinase 12 (CDK12)
|
|
27.317 (56/205) |
1.49E-12 |
Activin receptor type IIB (ACVR2B)
|
|
23.024 (67/291) |
1.61E-12 |
Protein kinase G1 (PRKG1)
|
|
25.984 (66/254) |
1.62E-12 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
28.788 (76/264) |
1.66E-12 |
Doublecortin-like kinase 1 (DCLK1)
|
|
24.775 (55/222) |
1.69E-12 |
Serine/threonine-protein kinase NLK (NLK)
|
|
25.871 (52/201) |
1.78E-12 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
28.713 (58/202) |
2.05E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
27.511 (63/229) |
2.21E-12 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
20.195 (62/307) |
2.43E-12 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
26.038 (69/265) |
2.58E-12 |
Doublecortin-like kinase 2 (DCLK2)
|
|
22.909 (63/275) |
3.11E-12 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
25.097 (65/259) |
3.41E-12 |
Checkpoint kinase-1 (CHK1)
|
|
28.505 (61/214) |
3.43E-12 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
26.667 (56/210) |
4.02E-12 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
27.919 (55/197) |
4.11E-12 |
Oxidative stress responsive 1 (OXSR1)
|
|
24.514 (63/257) |
4.21E-12 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
23.675 (67/283) |
4.63E-12 |
Protein kinase N2 (PKN2)
|
|
28.279 (69/244) |
5.54E-12 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
24.554 (55/224) |
5.96E-12 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
27.602 (61/221) |
6.13E-12 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
27.149 (60/221) |
6.33E-12 |
Protein kinase D (PRKD1)
|
|
27.700 (59/213) |
6.93E-12 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
29.333 (66/225) |
7.08E-12 |
MEK kinase kinase 4 (MAP4K4)
|
|
25.481 (53/208) |
8.47E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
26.638 (61/229) |
9.67E-12 |
Yet another novel kinase 2 (STK32B)
|
|
22.989 (60/261) |
1.03E-11 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
25.112 (56/223) |
1.05E-11 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
28.922 (59/204) |
1.10E-11 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.229 (55/218) |
1.20E-11 |
Serine/threonine-protein kinase 10 (STK10)
|
|
26.087 (66/253) |
1.27E-11 |
Dual specificity protein kinase TTK (MPS1)
|
|
23.022 (64/278) |
1.43E-11 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
24.873 (49/197) |
1.53E-11 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.724 (62/232) |
1.57E-11 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
26.000 (65/250) |
1.95E-11 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
32.124 (62/193) |
2.29E-11 |
Protein kinase C eta type (PRKCH)
|
|
24.434 (54/221) |
2.29E-11 |
Cyclin-dependent kinase 10 (CDK10)
|
|
27.885 (58/208) |
2.34E-11 |
TGF-beta receptor type I (TGFBR1)
|
|
25.106 (59/235) |
2.38E-11 |
PAK-2 protein kinase (PAK2)
|
|
24.390 (50/205) |
2.56E-11 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
27.049 (66/244) |
3.06E-11 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
25.837 (54/209) |
3.09E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
27.155 (63/232) |
3.30E-11 |
Ste-20-related kinase (STK39)
|
|
23.077 (60/260) |
3.35E-11 |
Testis-specific serine kinase 2 (TSSK2)
|
|
26.293 (61/232) |
3.50E-11 |
Activin receptor type IIA (ACVR2A)
|
|
22.759 (66/290) |
3.73E-11 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
23.397 (73/312) |
4.07E-11 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
23.109 (55/238) |
4.31E-11 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
27.670 (57/206) |
4.99E-11 |
Myosin-IIIa (MYO3A)
|
|
22.794 (62/272) |
6.75E-11 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
21.825 (55/252) |
7.36E-11 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
23.864 (63/264) |
7.62E-11 |
MEK kinase kinase 2 (MAP4K2)
|
|
26.000 (52/200) |
7.71E-11 |
Cyclin-dependent kinase 4 (CDK4)
|
|
26.733 (54/202) |
8.14E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
27.193 (62/228) |
8.33E-11 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
26.875 (43/160) |
9.27E-11 |
MEK kinase kinase 3 (MAP4K3)
|
|
26.020 (51/196) |
9.74E-11 |
Activin receptor type IB (ACVR1B)
|
|
25.592 (54/211) |
1.02E-10 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
23.077 (45/195) |
1.11E-10 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
27.228 (55/202) |
1.18E-10 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
24.554 (55/224) |
1.21E-10 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.754 (61/228) |
1.54E-10 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
23.077 (48/208) |
1.56E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
22.388 (45/201) |
1.72E-10 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
23.144 (53/229) |
1.79E-10 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
26.887 (57/212) |
2.16E-10 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
28.986 (60/207) |
2.69E-10 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
23.182 (51/220) |
2.72E-10 |
PIM-3 protein kinase (PIM3)
|
|
27.660 (78/282) |
2.85E-10 |
Cytoplasmic DRAK1 (STK17A)
|
|
28.049 (46/164) |
3.44E-10 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
24.658 (54/219) |
3.58E-10 |
Cyclin-dependent kinase 20 (CDK20)
|
|
26.180 (61/233) |
3.59E-10 |
PAK-1 protein kinase (PAK1)
|
|
22.596 (47/208) |
3.63E-10 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
29.319 (56/191) |
3.84E-10 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
22.088 (55/249) |
4.58E-10 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
23.616 (64/271) |
4.58E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
25.000 (45/180) |
5.60E-10 |
Cyclin-dependent kinase 7 (CDK7)
|
|
28.141 (56/199) |
6.03E-10 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.540 (56/211) |
6.40E-10 |
Cyclin-dependent kinase 9 (CDK9)
|
|
26.961 (55/204) |
6.61E-10 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
29.237 (69/236) |
7.40E-10 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
25.701 (55/214) |
7.73E-10 |
Triple functional domain protein (TRIO)
|
|
29.104 (78/268) |
8.05E-10 |
PAK-4 protein kinase (PAK4)
|
|
22.613 (45/199) |
8.51E-10 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
27.317 (56/205) |
9.91E-10 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
24.615 (64/260) |
1.02E-09 |
Titin (TTN)
|
24.091 (53/220) |
1.11E-09 |
ERK activator kinase 1 (MEK1)
|
|
26.540 (56/211) |
1.28E-09 |
TAO kinase 1 (TAOK1)
|
|
27.861 (56/201) |
1.61E-09 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
24.424 (53/217) |
1.67E-09 |
Rhodopsin kinase GRK7 (GRK7)
|
|
26.667 (64/240) |
1.93E-09 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
23.954 (63/263) |
1.96E-09 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
34.737 (33/95) |
1.99E-09 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
23.200 (58/250) |
2.09E-09 |
Bone morphogenetic protein receptor (BMPR2)
|
|
27.315 (59/216) |
2.23E-09 |
Obscurin (OBSCN)
|
|
27.660 (52/188) |
2.35E-09 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
25.238 (53/210) |
2.39E-09 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
27.368 (52/190) |
2.50E-09 |
BMP-2-inducible protein kinase (BMP2K)
|
|
24.354 (66/271) |
2.53E-09 |
Protein kinase G2 (PRKG2)
|
|
23.333 (70/300) |
3.21E-09 |
Nik-related protein kinase (NRK)
|
|
23.276 (54/232) |
3.28E-09 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
27.000 (54/200) |
3.39E-09 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
24.887 (55/221) |
3.58E-09 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
29.730 (33/111) |
3.76E-09 |
Tau-tubulin kinase (TTBK1)
|
|
26.697 (59/221) |
5.41E-09 |
Cyclin-G-associated kinase (GAK)
|
|
23.466 (65/277) |
5.84E-09 |
Serine/threonine-protein kinase cot (COT)
|
|
26.816 (48/179) |
7.34E-09 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
24.257 (49/202) |
7.57E-09 |
Protein kinase N1 (PKN1)
|
|
27.092 (68/251) |
8.89E-09 |
Protein kinase C iota (PRKCI)
|
|
23.457 (57/243) |
9.07E-09 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
22.400 (56/250) |
9.17E-09 |
ERK activator kinase 2 (MEK2)
|
|
27.111 (61/225) |
1.14E-08 |
Protein kinase C zeta (PRKCZ)
|
|
23.944 (51/213) |
1.24E-08 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
26.000 (52/200) |
1.28E-08 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
21.610 (51/236) |
1.61E-08 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
30.435 (35/115) |
1.62E-08 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
24.561 (56/228) |
1.63E-08 |
Tau-tubulin kinase 2 (TTBK2)
|
|
25.792 (57/221) |
1.71E-08 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
26.887 (57/212) |
1.94E-08 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
24.510 (50/204) |
2.33E-08 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
25.000 (61/244) |
2.66E-08 |
STE20-related kinase adapter protein beta (STRADB)
|
|
23.047 (59/256) |
2.83E-08 |
ERK activator kinase 7 (MAP2K7)
|
|
24.615 (64/260) |
5.20E-08 |
Protein kinase N3 (PKN3)
|
|
27.200 (68/250) |
6.27E-08 |
Myosin-IIIb (MYO3B)
|
|
24.453 (67/274) |
6.61E-08 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
26.180 (61/233) |
7.88E-08 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
26.563 (51/192) |
8.61E-08 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
27.803 (62/223) |
1.06E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
26.108 (53/203) |
1.18E-07 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.312 (53/218) |
1.35E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
25.541 (59/231) |
1.56E-07 |
TAO kinase 3 (TAOK3)
|
|
27.895 (53/190) |
1.57E-07 |
Casein kinase I epsilon (CSNK1E)
|
|
22.744 (63/277) |
1.83E-07 |
Casein kinase I delta (CSNK1D)
|
|
22.744 (63/277) |
2.09E-07 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
24.615 (48/195) |
2.34E-07 |
NF-kappa-B-activating kinase (TBK1)
|
|
30.043 (70/233) |
2.36E-07 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
28.846 (30/104) |
2.48E-07 |
Kalirin (KALRN)
|
|
25.283 (67/265) |
2.77E-07 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
25.532 (60/235) |
3.46E-07 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
25.153 (41/163) |
3.60E-07 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
24.413 (52/213) |
3.60E-07 |
Rhodopsin kinase GRK1 (GRK1)
|
|
28.125 (36/128) |
5.03E-07 |
Cyclin-dependent kinase 8 (CDK8)
|
|
24.155 (50/207) |
7.11E-07 |
CDC-like kinase 4 (CLK4)
|
|
25.676 (57/222) |
7.95E-07 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
27.215 (43/158) |
8.05E-07 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
26.214 (54/206) |
9.17E-07 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
26.866 (54/201) |
9.20E-07 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
26.577 (59/222) |
9.77E-07 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
27.097 (42/155) |
9.83E-07 |
Adaptor-associated kinase 1 (AAK1)
|
|
22.383 (62/277) |
1.09E-06 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.244 (58/221) |
1.20E-06 |
CDC-like kinase 1 (CLK1)
|
|
26.126 (58/222) |
1.23E-06 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
30.288 (63/208) |
1.24E-06 |
Cyclin-dependent kinase 19 (CDK19)
|
|
24.155 (50/207) |
1.73E-06 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
24.554 (55/224) |
1.98E-06 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
25.778 (58/225) |
2.16E-06 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
26.244 (58/221) |
2.86E-06 |
Membrane-associated kinase (PKMYT1)
|
|
25.000 (76/304) |
3.03E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
24.424 (53/217) |
3.05E-06 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
24.887 (55/221) |
3.11E-06 |
TGF-beta-stimulated factor 1 (STK16)
|
|
19.780 (54/273) |
4.99E-06 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
27.044 (43/159) |
5.27E-06 |
CDC-like kinase 3 (CLK3)
|
|
25.217 (58/230) |
6.19E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
25.000 (57/228) |
6.66E-06 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
24.841 (39/157) |
7.27E-06 |
Casein kinase I alpha (CSNK1A1)
|
|
22.222 (64/288) |
7.32E-06 |
Casein kinase I isoform alpha-like (CSNK1A1L)
|
|
22.759 (66/290) |
7.45E-06 |
Casein kinase II alpha (CSNK2A1)
|
|
21.333 (48/225) |
9.64E-06 |
Peripheral plasma membrane protein CASK (CASK)
|
|
23.158 (44/190) |
1.38E-05 |
PDZ binding kinase (PBK)
|
|
23.967 (58/242) |
1.44E-05 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.000 (52/208) |
1.58E-05 |
Myotonin-protein kinase (DMPK)
|
|
22.467 (51/227) |
2.10E-05 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
28.638 (61/213) |
3.42E-05 |
Casein kinase II alpha prime (CSNK2A2)
|
|
20.889 (47/225) |
3.47E-05 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
24.026 (37/154) |
3.84E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.210 (60/238) |
3.85E-05 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
20.889 (47/225) |
4.14E-05 |
Citron Rho-interacting kinase (CIT)
|
|
29.630 (32/108) |
4.97E-05 |
Serine/threonine-protein kinase 40 (STK40)
|
|
25.625 (41/160) |
5.15E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
24.464 (57/233) |
5.83E-05 |
Serine/threonine-protein kinase PINK1, mitochondrial (PINK1)
|
|
27.439 (45/164) |
5.97E-05 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.020 (49/204) |
6.72E-05 |
Tribbles homolog 2 (TRIB2)
|
|
24.870 (48/193) |
7.95E-05 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
26.220 (43/164) |
8.20E-05 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
24.800 (31/125) |
8.21E-05 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
24.528 (26/106) |
8.56E-05 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
22.259 (67/301) |
1.15E-04 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
24.171 (51/211) |
1.20E-04 |
SRSF protein kinase 1 (SRPK1)
|
|
29.371 (42/143) |
1.24E-04 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.394 (51/218) |
1.59E-04 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
25.641 (70/273) |
2.04E-04 |
Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8L2)
|
|
38.095 (32/84) |
2.20E-04 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
26.271 (31/118) |
2.88E-04 |
Ribosomal protein S6 kinase-like 1 (RPS6KL1)
|
|
27.027 (30/111) |
3.24E-04 |
Large tumor suppressor homolog 2 (LATS2)
|
|
19.476 (52/267) |
3.48E-04 |
NDR1 protein kinase (STK38)
|
|
19.920 (50/251) |
5.31E-04 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
21.717 (43/198) |
7.34E-04 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
25.725 (71/276) |
7.62E-04 |
NDR2 protein kinase (STK38L)
|
|
19.368 (49/253) |
8.49E-04 |
SRSF protein kinase 3 (SRPK3)
|
|
27.465 (39/142) |
1.00E-03 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
23.902 (49/205) |
1.00E-03 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
23.780 (39/164) |
1.00E-03 |
CDC-like kinase 2 (CLK2)
|
|
22.822 (55/241) |
2.00E-03 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
21.970 (29/132) |
2.00E-03 |
SRSF protein kinase 2 (SRPK2)
|
|
27.742 (43/155) |
2.00E-03 |
Ribosomal protein S6 kinase delta-1 (RPS6KC1)
|
|
25.166 (38/151) |
3.00E-03 |
Inactive serine/threonine-protein kinase VRK3 (VRK3)
|
|
22.727 (45/198) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |